SEARCH

SEARCH BY CITATION

References

  • 1
    Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993;27:832840.
  • 2
    Pouyanne P, Haramburu F, Imbs JL, Begaud B. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. BMJ 2000;320:1036.
  • 3
    Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:12001205.
  • 4
    Sullivan TJ, Remedios C, Ong MD, Gilliam LK. Studies of the multiple drug allergy syndrome. J Allergy Clin Immunol 1989;83:270.
  • 5
    Asero R. Multiple sensitivity to NSAID. Allergy 2000;55:893894.
  • 6
    Schiavino D, Nucera E, Roncallo C, Pollastrini E, De Pasquale T, Lombardo C et al. Multiple-drug intolerance syndrome: clinical findings and usefulness of challenge tests. Ann Allergy Asthma Immunol 2007;99:136142.
  • 7
    Neukomm CB, Yawalkar N, Helbling A, Pichler WJ. T-cell reactions to drugs in distinct clinical manifestations of drug allergy. J Investig Allergol Clin Immunol 2001;11:275284.
  • 8
    Gex-Collet C, Helbling A, Pichler WJ. Multiple drug hypersensitivity – proof of multiple drug hypersensitivity by patch and lymphocyte transformation tests. J Investig Allergol Clin Immunol 2005;15:293296.
  • 9
    Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004;59:809820.
  • 10
    Cavani A, Nasorri F, Ottaviani C, Sebastiani S, De Pita O, Girolomoni G. Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J Immunol 2003;171:57605768.
  • 11
    Takahashi R, Kano Y, Yamazaki Y, Kimishima M, Mizukawa Y, Shiohara T. Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol 2009;182:80718079.
  • 12
    Mauri-Hellweg D, Zanni M, Frei E, Bettens F, Brander C, Mauri D et al. Cross-reactivity of T cell lines and clones to beta-lactam antibiotics. J Immunol 1996;157:10711079.
  • 13
    von Greyerz S, Zanni MP, Frutig K, Schnyder B, Burkhart C, Pichler WJ. Interaction of sulfonamide derivatives with the TCR of sulfamethoxazole-specific human alpha beta+ T cell clones. J Immunol 1999;162:595602.
  • 14
    Schmid DA, Depta JP, Pichler WJ. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. Clin Exp Allergy 2006;36:5969.
  • 15
    Schmid DA, Depta JP, Luthi M, Pichler WJ. Transfection of drug-specific T-cell receptors into hybridoma cells: tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds. Mol Pharmacol 2006;70:356365.
  • 16
    Lerch M, Keller M, Britschgi M, Kanny G, Tache V, Schmid DA et al. Cross-reactivity patterns of T cells specific for iodinated contrast media. J Allergy Clin Immunol 2007;119:15291536.
  • 17
    Gambineri E, Perroni L, Passerini L, Bianchi L, Doglioni C, Meschi F et al. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J Allergy Clin Immunol 2008;122:11051112.e1.
  • 18
    Nassif A, Bensussan A, Boumsell L, Deniaud A, Moslehi H, Wolkenstein P et al. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol 2004;114:12091215.
  • 19
    Sester U, Presser D, Dirks J, Gartner BC, Kohler H, Sester M. PD-1 expression and IL-2 loss of cytomegalovirus-specific T cells correlates with viremia and reversible functional anergy. Am J Transplant 2008;8:14861497.
  • 20
    Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpes viruses and antiviral and antidrug immune responses. Allergol Int 2006;55:18.
  • 21
    Picard D, Janela B, Descamps V, D’Incan M, Courville P, Jacquot S et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med 2010;2:46ra62.